Palatin Technologies Inc (PTN)
1.79
-0.03
(-1.65%)
USD |
NYAM |
Apr 29, 16:00
1.79
0.00 (0.00%)
After-Hours: 18:07
Palatin Technologies Free Cash Flow: -26.75M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.75M |
| September 30, 2023 | -26.04M |
| June 30, 2023 | -28.85M |
| March 31, 2023 | -26.95M |
| December 31, 2022 | -35.85M |
| September 30, 2022 | -32.43M |
| June 30, 2022 | -30.18M |
| March 31, 2022 | -30.96M |
| December 31, 2021 | -24.91M |
| September 30, 2021 | -32.95M |
| June 30, 2021 | -22.65M |
| March 31, 2021 | -20.19M |
| December 31, 2020 | -19.20M |
| September 30, 2020 | -9.698M |
| June 30, 2020 | 41.26M |
| March 31, 2020 | 40.39M |
| December 31, 2019 | 39.06M |
| September 30, 2019 | 38.49M |
| June 30, 2019 | -21.82M |
| March 31, 2019 | -4.393M |
| December 31, 2018 | -7.780M |
| September 30, 2018 | -5.282M |
| June 30, 2018 | 1.681M |
| March 31, 2018 | -21.69M |
| December 31, 2017 | 29.05M |
| Date | Value |
|---|---|
| September 30, 2017 | 20.91M |
| June 30, 2017 | 12.88M |
| March 31, 2017 | 12.07M |
| December 31, 2016 | -41.65M |
| September 30, 2016 | -44.56M |
| June 30, 2016 | -47.38M |
| March 31, 2016 | -43.15M |
| December 31, 2015 | -38.25M |
| September 30, 2015 | -28.50M |
| June 30, 2015 | -13.36M |
| March 31, 2015 | -8.407M |
| December 31, 2014 | -4.593M |
| September 30, 2014 | -4.437M |
| June 30, 2014 | -12.21M |
| March 31, 2014 | -12.76M |
| December 31, 2013 | -14.57M |
| September 30, 2013 | -11.02M |
| June 30, 2013 | -13.71M |
| March 31, 2013 | -14.08M |
| December 31, 2012 | -13.89M |
| September 30, 2012 | -16.26M |
| June 30, 2012 | -15.50M |
| March 31, 2012 | -13.21M |
| December 31, 2011 | -12.77M |
| September 30, 2011 | -10.79M |
Free Cash Flow Range, Past 5 Years
-35.85M
Minimum
Dec 2022
41.26M
Maximum
Jun 2020
-12.12M
Average
-24.91M
Median
Dec 2021
Free Cash Flow Benchmarks
| Oragenics Inc | -7.291M |
| Outset Medical Inc | -134.81M |
| Ligand Pharmaceuticals Inc | -4.272M |
| Galectin Therapeutics Inc | -32.96M |
| ADMA Biologics Inc | 3.819M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.48M |
| Cash from Investing (Quarterly) | 9.462M |
| Cash from Financing (Quarterly) | 4.974M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -10.51M |
| Free Cash Flow to Firm (Quarterly) | -10.51M |
| Free Cash Flow Yield | -121.0% |